Moser AB - Search Results

1

Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening.

Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD, Kass NE, Moser HW. Bezman L, et al. Among authors: moser hw, moser ab. Ann Neurol. 2001 Apr;49(4):512-7. Ann Neurol. 2001. PMID: 11310629

2

Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening.

Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW. Dubey P, et al. Among authors: moser hw, moser ab. J Pediatr. 2005 Apr;146(4):528-32. doi: 10.1016/j.jpeds.2004.10.067. J Pediatr. 2005. PMID: 15812458

3

Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.

Moser HW, Raymond GV, Lu SE, Muenz LR, Moser AB, Xu J, Jones RO, Loes DJ, Melhem ER, Dubey P, Bezman L, Brereton NH, Odone A. Moser HW, et al. Among authors: moser ab. Arch Neurol. 2005 Jul;62(7):1073-80. doi: 10.1001/archneur.62.7.1073. Arch Neurol. 2005. PMID: 16009761

4

Cognitive evaluation of neurologically asymptomatic boys with X-linked adrenoleukodystrophy.

Cox CS, Dubey P, Raymond GV, Mahmood A, Moser AB, Moser HW. Cox CS, et al. Among authors: moser hw, moser ab. Arch Neurol. 2006 Jan;63(1):69-73. doi: 10.1001/archneur.63.1.69. Arch Neurol. 2006. PMID: 16401737

5

"Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.

Moser HW, Moser AB, Hollandsworth K, Brereton NH, Raymond GV. Moser HW, et al. Among authors: moser ab. J Mol Neurosci. 2007 Sep;33(1):105-13. doi: 10.1007/s12031-007-0041-4. J Mol Neurosci. 2007. PMID: 17901554 Review.

6

Newborn screening for adrenoleukodystrophy: implications for therapy.

Raymond GV, Jones RO, Moser AB. Raymond GV, et al. Among authors: moser ab. Mol Diagn Ther. 2007;11(6):381-4. doi: 10.1007/BF03256261. Mol Diagn Ther. 2007. PMID: 18078355 Review.

7

Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy.

Turk BR, Theisen BE, Nemeth CL, Marx JS, Shi X, Rosen M, Jones RO, Moser AB, Watkins PA, Raymond GV, Tiffany C, Fatemi A. Turk BR, et al. Among authors: moser ab. JAMA Neurol. 2017 May 1;74(5):519-524. doi: 10.1001/jamaneurol.2016.5715. JAMA Neurol. 2017. PMID: 28288261 Free PMC article.

8

Adrenoleukodystrophy: phenotypic variability and implications for therapy.

Moser HW, Moser AB, Smith KD, Bergin A, Borel J, Shankroff J, Stine OC, Merette C, Ott J, Krivit W, et al. Moser HW, et al. Among authors: moser ab. J Inherit Metab Dis. 1992;15(4):645-64. doi: 10.1007/BF01799621. J Inherit Metab Dis. 1992. PMID: 1528023 Review.

9

Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy.

Moser HW, Moser AB, Naidu S, Bergin A. Moser HW, et al. Among authors: moser ab. Dev Neurosci. 1991;13(4-5):254-61. doi: 10.1159/000112170. Dev Neurosci. 1991. PMID: 1817030 Review.

10

Adrenoleukodystrophy and Zellweger syndrome.

Moser HW, Moser AB, Chen WW, Watkins PA. Moser HW, et al. Among authors: moser ab. Prog Clin Biol Res. 1990;321:511-35. Prog Clin Biol Res. 1990. PMID: 2183241 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page